AGENUS Stock Price
$3.94 
Change:
0.11 1.44% Volume:
5,474
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 3.96 | Todays Low: 3.75 | Open: 3.83 | Last Close: 3.76
52 Wk High: 5.47 | 52 Wk Low: 3.4 | Todays Pivot: 3.88 | Pre market open: 5.74
Sector: 
Online News For Agenus
|
Agenus's Buy Rating Reaffirmed at Maxim Group (AGEN) - Zolmax
Wed, 19 Jun 2013 14:34Agenus logo Agenus (NASDAQ: AGEN)'s stock had its “buy” rating reiterated by analysts at Maxim Group in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports. They currently have a $19.00 price objective on the stock ...
|
|
Agenus's "Buy" Rating Reaffirmed at Maxim Group (AGEN) - The Utah People's Post
Tue, 18 Jun 2013 18:26Agenus logo Agenus (NASDAQ: AGEN)'s stock had its “buy” rating reiterated by research analysts at Maxim Group in a report released on Tuesday, TheFlyOnTheWall.com reports. They currently have a $19.00 target price on the stock. Maxim Group's price ...
|
|
Agenus' Annual Shareholder Meeting (Transcript) - Seeking Alpha
Thu, 13 Jun 2013 04:04Good day ladies and gentlemen and welcome to the Agenus Annual Shareholders Meeting Conference Call. As a reminder, today's conference is being recorded. At this time, I'd like to turn the conference over to Ms. Karen Valentine please go head miss.
|
|
Agenus to Webcast Annual Shareholders' Meeting - GlobeNewswire (press release)
Mon, 10 Jun 2013 14:43LEXINGTON, Mass., June 10, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) invites investors and the general public to its Annual Shareholders' Meeting at 5:00 p.m. ET on Wednesday, June 12, 2013. The meeting will be held at the company's ...
|
|
Agenus begins Phase 2 trials of brain tumor vaccine - Boston Business Journal (blog)
Wed, 22 May 2013 21:00Garo Armen, CEO of Agenus said the National Cancer Institute is footing the bill for the entire 222-patient Phase 2 trial of its Prophage G-200 compound targeting adults with recurrent brain tumors and estimates the cost of the trial if funded ...
|
|
Deadly Tree Disease Spreads, Scientists Work on Genes to Save Them - Care2.com (blog)
Wed, 19 Jun 2013 13:12The researchers have been examining a genus of ash tree known as “Tree 35,” a strain bred in Denmark nearly 100 years ago that has shown an ability to withstand fungal infection even while nearly all other Danish ash strains have been wiped out ...
|
AGEN Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Agenus quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for AGEN to choose from. Visit here to build your stock quote widget »
